Page last updated: 2024-12-06

noxiptilin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

noxiptilin: proposed tricyclic antidepressent; minor descriptor (75-86); on line & INDEX MEDICUS search DIBENZOCYCLOHEPTENES (75-86); RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID21087
CHEMBL ID1697689
CHEBI ID135232
SCHEMBL ID49824
MeSH IDM0263132

Synonyms (32)

Synonym
10,11-dihydro-5h-dibenzo[a,d]cyclohepten-5-one o-[2-dimethylamino)ethyl]oxime
noxiptiline
bay 1521
CHEBI:135232
AKOS005065839
bay-1521
CHEMBL1697689
noxiptyline
noxiptilin
noxiptilinum
10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-on-o-(2-(dimethylamino)ethyl)oxim
10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-one o-(2-(dimethylamino)ethyl)oxime
noxiptilinum [inn-latin]
df7d3ny7el ,
noxiptiline [inn:ban:dcf]
unii-df7d3ny7el
3362-45-6
noxiptilina
10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-one o-(2-dimethylamino)ethyl)oxime
noxiptilina [inn-spanish]
noxiptilin [mi]
10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-one o-((2-dimethylamino)ethyl)oxime
noxiptiline [inn]
noxiptiline [who-dd]
SCHEMBL49824
GPTURHKXTUDRPC-UHFFFAOYSA-N
dibenzoxin
noxiptylin
DTXSID10187311
Q7067311
n,n-dimethyl-2-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylideneamino)oxyethanamine
dimethyl({2-[({tricyclo[9.4.0.0?,?]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene}amino)oxy]ethyl})amine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic tricyclic compound
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
AID588208Literature-mined public compounds from Lowe et al phospholipidosis modelling dataset2010Molecular pharmaceutics, Oct-04, Volume: 7, Issue:5
Predicting phospholipidosis using machine learning.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]